- #ASCO26: Summit, Akeso drug reduces death by 34% in China lung cancer studyCHICAGO — The leading drug in biopharma's hottest immunotherapy race reduced the risk of death by 34% in previously untreated Chinese lung cancer patients, compared to standard immunotherapy plus c…Endpoints · 1mo ago↗ source
- #ASCO26: Personalized cancer vaccines may help brain cancer patients live longerPersonalized cancer vaccines might make notoriously deadly brain cancers more susceptible to immunotherapy and possibly prolong survival for some patients, according to new research from the Dana-F…Endpoints · 1mo ago↗ source
- #ASCO26: Grail’s cancer blood test isn’t ready for widespread use, experts sayCHICAGO — Grail's blood test, which it has pitched as a way to spot a variety of cancers early in their growth, still isn't ready to be used as a regular screening tool, experts not involved ...